The Small Molecule Drug Development Shared Resource (SR) optimizes robust assays in 384-well format and to screen large chemical libraries to identify new small molecules for innovative cancer therapeutics.
Services
| Service/Expertise | Cost | Description |
|---|---|---|
| Initial consultation | None | Investigators receive feedback regarding assay development/HTS goals, while Director and Managing Director suggest optimal assay approaches |
| Facility orientation/training | $200/ session | 2-hr session covering all instruments |
| Operetta microscope, hourly usage | $40/hour | Enables investigators to benefit from automated |
| Managing Director support | $100/hour | General support in assay development and execution |
| Bioactives Library access (3,200 cpds) | $200 | Enables pilot screening |
| HTS Library access (50,000 molecules) | $2,000 | Enables HTS |
| All-inclusive screening packages | Quotes available | Enables dedicated % effort from Managing Director, library access, and equipment time. Can include reagent costs. Priced on a per-project basis due to varying assay needs. |
Contact for More Information
Director: Drew Adams, PhD
216.368.4922
dja59@case.edu
Managing Director: Yuriy Fedorov, PhD
216.368.1506
yuriy.fedorov@case.edu